371 studies found for: Open Studies | "Myelodysplastic Syndromes"
Study of DSP-7888 in Patients With Myelodysplastic Syndrome
Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome
Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome
PREDICTive FactOR of Overall Survival Among Geriatric Assessment Tools and Disease Related Factors in Elderly Patients With High Risk Myelodysplastic Syndromes.
Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients
Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome
Safety and Efficacy Study of CC-486 and Durvalumab in Subjects With Myelodysplastic Syndromes
|9||Not yet recruiting||
Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)
The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study
Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome
Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS)
ACE-536 Extension Study - Myelodysplastic Syndromes
Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes
Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome
Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes
A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome
Tipifarnib in Subjects With Transfusion-dependent, Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
An Open-Label Study of Recormon (Epoetin Beta) Treatment in Anemic Patients With Myelodysplastic Syndrome
A Safety and Pharmacology Study of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) Administered Alone or in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
† Study has passed its completion date and status has not been verified in more than two years.